• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FACEmemory®,一个用于情景记忆预筛查的创新型在线平台:来自前 3000 名参与者的发现。

FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.

机构信息

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.

Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

出版信息

J Alzheimers Dis. 2024;97(3):1173-1187. doi: 10.3233/JAD-230983.

DOI:10.3233/JAD-230983
PMID:38217602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10977414/
Abstract

BACKGROUND

The FACEmemory® online platform comprises a complex memory test and sociodemographic, medical, and family questions. This is the first study of a completely self-administered memory test with voice recognition, pre-tested in a memory clinic, sensitive to Alzheimer's disease, using information and communication technologies, and offered freely worldwide.

OBJECTIVE

To investigate the demographic and clinical variables associated with the total FACEmemory score, and to identify distinct patterns of memory performance on FACEmemory.

METHODS

Data from the first 3,000 subjects who completed the FACEmemory test were analyzed. Descriptive analyses were applied to demographic, FACEmemory, and medical and family variables; t-test and chi-square analyses were used to compare participants with preserved versus impaired performance on FACEmemory (cut-off = 32); multiple linear regression was used to identify variables that modulate FACEmemory performance; and machine learning techniques were applied to identify different memory patterns.

RESULTS

Participants had a mean age of 50.57 years and 13.65 years of schooling; 64.07% were women, and 82.10% reported memory complaints with worries. The group with impaired FACEmemory performance (20.40%) was older, had less schooling, and had a higher prevalence of hypertension, diabetes, dyslipidemia, and family history of neurodegenerative disease than the group with preserved performance. Age, schooling, sex, country, and completion of the medical and family history questionnaire were associated with the FACEmemory score. Finally, machine learning techniques identified four patterns of FACEmemory performance: normal, dysexecutive, storage, and completely impaired.

CONCLUSIONS

FACEmemory is a promising tool for assessing memory in people with subjective memory complaints and for raising awareness about cognitive decline in the community.

摘要

背景

FACEmemory®在线平台包括一个复杂的记忆测试以及社会人口学、医学和家庭问题的相关信息。这是第一个使用信息和通信技术,对经过预测试的、完全自我管理的、对阿尔茨海默病敏感的、带有语音识别功能的记忆测试进行的研究,该测试在记忆诊所中进行,目前在全球范围内免费提供。

目的

研究与 FACEmemory 总评分相关的人口统计学和临床变量,并确定 FACEmemory 上记忆表现的不同模式。

方法

分析了前 3000 名完成 FACEmemory 测试的受试者的数据。对人口统计学、FACEmemory 以及医学和家庭变量进行描述性分析;使用 t 检验和卡方检验比较 FACEmemory 表现正常和受损的参与者(分界值=32);使用多元线性回归识别调节 FACEmemory 表现的变量;并应用机器学习技术识别不同的记忆模式。

结果

参与者的平均年龄为 50.57 岁,平均受教育年限为 13.65 年;64.07%为女性,82.10%报告有记忆问题和担忧。FACEmemory 表现受损(20.40%)的组年龄较大,受教育程度较低,且高血压、糖尿病、血脂异常和神经退行性疾病家族史的患病率较高。年龄、受教育程度、性别、国家以及完成医学和家庭史问卷与 FACEmemory 评分相关。最后,机器学习技术确定了 FACEmemory 表现的四种模式:正常、执行功能障碍、存储和完全受损。

结论

FACEmemory 是一种有前途的评估有主观记忆主诉的人群的记忆的工具,并提高了对社区认知能力下降的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79e1/10977414/6875399e6ae5/jad-97-jad230983-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79e1/10977414/b87cdae2e028/jad-97-jad230983-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79e1/10977414/6875399e6ae5/jad-97-jad230983-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79e1/10977414/b87cdae2e028/jad-97-jad230983-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79e1/10977414/6875399e6ae5/jad-97-jad230983-g002.jpg

相似文献

1
FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.FACEmemory®,一个用于情景记忆预筛查的创新型在线平台:来自前 3000 名参与者的发现。
J Alzheimers Dis. 2024;97(3):1173-1187. doi: 10.3233/JAD-230983.
2
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.自动化FACEmemory®评分与早发性轻度认知障碍中的阿尔茨海默病表型和生物标志物相关:BIOFACE队列研究
Alzheimers Res Ther. 2022 Mar 18;14(1):43. doi: 10.1186/s13195-022-00988-8.
3
A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.一种用于早期检测阿尔茨海默病的人脸联想记忆测验(FACEmemory®)简体中文简化版的计算机版本。
Alzheimers Res Ther. 2020 Mar 16;12(1):25. doi: 10.1186/s13195-020-00594-6.
4
FACEmemory, an Innovative Self-Administered Online Memory Assessment Tool.FACEmemory,一种创新的自我管理在线记忆评估工具。
J Clin Med. 2024 Nov 29;13(23):7274. doi: 10.3390/jcm13237274.
5
Episodic-Memory Performance in Machine Learning Modeling for Predicting Cognitive Health Status Classification.机器学习模型在预测认知健康状况分类中的情景记忆表现。
J Alzheimers Dis. 2019;70(1):277-286. doi: 10.3233/JAD-190165.
6
Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI.评估正常认知和轻度认知障碍患者情景记忆轨迹:来自 ADNI 的结果。
PLoS One. 2019 Feb 25;14(2):e0212435. doi: 10.1371/journal.pone.0212435. eCollection 2019.
7
Self-reported and informant-reported memory functioning and awareness in patients with mild cognitive impairment and Alzheimer´s disease.轻度认知障碍和阿尔茨海默病患者的自我报告及他人报告的记忆功能与意识
Neuropsychiatr. 2016 Jun;30(2):103-12. doi: 10.1007/s40211-016-0185-y. Epub 2016 Jun 13.
8
Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.正常老年人气味的情景记忆对阿尔茨海默病生物标志物进行分层。
Ann Neurol. 2016 Dec;80(6):846-857. doi: 10.1002/ana.24792. Epub 2016 Nov 23.
9
Using virtual reality to characterize episodic memory profiles in amnestic mild cognitive impairment and Alzheimer's disease: influence of active and passive encoding.使用虚拟现实技术刻画遗忘型轻度认知障碍和阿尔茨海默病的情景记忆特征:主动和被动编码的影响。
Neuropsychologia. 2012 Apr;50(5):592-602. doi: 10.1016/j.neuropsychologia.2011.12.013. Epub 2012 Jan 13.
10
Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross-sectional study of a large sample of older adults.使用简单的手部运动测试估算无症状发作性记忆障碍:一项对大量老年人进行的横断面研究。
Alzheimers Dement. 2024 Jan;20(1):173-182. doi: 10.1002/alz.13401. Epub 2023 Jul 30.

引用本文的文献

1
FACEmemory, an Innovative Self-Administered Online Memory Assessment Tool.FACEmemory,一种创新的自我管理在线记忆评估工具。
J Clin Med. 2024 Nov 29;13(23):7274. doi: 10.3390/jcm13237274.
2
Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer's disease spectrum.揭示认知状态的声音:基于机器学习的阿尔茨海默病谱系中的言语分析。
Alzheimers Res Ther. 2024 Feb 2;16(1):26. doi: 10.1186/s13195-024-01394-y.

本文引用的文献

1
Building a responsible innovation toolkit as project legacy.构建一个负责任的创新工具包作为项目遗产。
Front Res Metr Anal. 2023 Mar 13;8:1112106. doi: 10.3389/frma.2023.1112106. eCollection 2023.
2
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
3
Aducanumab for the treatment of Alzheimer's disease: a systematic review.阿杜卡奴单抗治疗阿尔茨海默病的系统评价。
Psychogeriatrics. 2023 May;23(3):512-522. doi: 10.1111/psyg.12944. Epub 2023 Feb 12.
4
Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies.全球 50 岁及以上社区居民轻度认知障碍的患病率:一项流行病学研究的荟萃分析和系统评价。
Age Ageing. 2022 Aug 2;51(8). doi: 10.1093/ageing/afac173.
5
Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review.轻度认知障碍和痴呆的数字认知生物标志物:一项系统综述。
J Clin Med. 2022 Jul 19;11(14):4191. doi: 10.3390/jcm11144191.
6
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.自动化FACEmemory®评分与早发性轻度认知障碍中的阿尔茨海默病表型和生物标志物相关:BIOFACE队列研究
Alzheimers Res Ther. 2022 Mar 18;14(1):43. doi: 10.1186/s13195-022-00988-8.
7
Identification of undiagnosed dementia cases using a web-based pre-screening tool: The MOPEAD project.使用基于网络的预筛查工具识别未确诊的痴呆病例:MOPEAD 项目。
Alzheimers Dement. 2021 Aug;17(8):1307-1316. doi: 10.1002/alz.12297. Epub 2021 Apr 15.
8
Validation and Normative Data of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME).面名联想记忆测验(S-FNAME)西班牙版本的验证和常模数据。
J Int Neuropsychol Soc. 2022 Jan;28(1):74-84. doi: 10.1017/S1355617721000084. Epub 2021 Mar 22.
9
The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial.计算机化认知综合测验(C3)在阿尔茨海默病二级预防试验中的应用。
J Prev Alzheimers Dis. 2021;8(1):59-67. doi: 10.14283/jpad.2020.38.
10
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.《痴呆症的预防、干预与照护:柳叶刀委员会2020年报告》
Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30.